India, March 3 -- image credit- shutterstock

Hyderabad-based biotechnology startup VeGen Labs LLP has been awarded Rs 3.765 crore Royalty-based financial support from Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise set-up by Department of Biotechnology.

This funding will support Investigational New Drug (IND)-enabling toxicology studies for IND126, a novel KRAS inhibitor, marking a significant step toward clinical development for Non-Small Cell Lung Cancer (NSCLC) patients in India.

Lung cancer remains one of the leading causes of cancer-related deaths in India, with NSCLC accounting for approximately 85% of all lung cancer cases. Each year, India reports over 70,000 new lung cancer cases, w...